Christopher M. Lindblom
Plus aucun poste en cours
Historique de carrière de Christopher M. Lindblom
Anciens postes connus de Christopher M. Lindblom
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 25/04/2016 | 25/07/2016 |
| Treasurer | 25/07/2016 | 01/10/2016 | |
| DNIB UNWIND INC | Directeur Administratif | 01/03/2014 | 21/03/2016 |
| Directeur Financier/CFO | 01/03/2014 | 21/03/2016 | |
| Secrétaire Général | 01/03/2014 | 21/03/2016 | |
| Treasurer | 01/03/2014 | 21/03/2016 | |
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/01/2006 | 12/04/2013 |
| Corporate Officer/Principal | 12/04/2013 | - | |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Directeur Financier/CFO | 07/06/2013 | 07/06/2013 |
| Corporate Officer/Principal | 07/06/2013 | 19/06/2013 | |
| Treasurer | 19/06/2013 | - |
Formation de Christopher M. Lindblom
| Boston College | Masters Business Admin |
| Syracuse University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Treasurer | 3 |
| Comptroller/Controller/Auditor | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
- Bourse
- Insiders
- Christopher M. Lindblom
- Expérience
